Topics in Antiviral Medicine 25 Issue 2 May/June 2017
BMC Public Health (2016) 16:766
DOI 10.1186/s12889-016-3455-5
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...t
regimen [1]. The number of these patients is not negligible.
In 2014, of the 6.3 million TB cases that were notified
by National TB Programmes (NTPs) to the World Health
Organization (WHO), approximately 700,000 patients were
already previously treated
more
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for... the first two to five products to become available in about 10 years.
more
Oxford Policy Management (OPM) - APW with UNAIDS (thru TSF)
WAHA International’s mHealth programme addresses several barriers to maternal and neonatal care, including: a lack of information at the community level about locally available services; a large distance from services and a lack of affordable transport for patients; and ineffective communication b...etween community-based and facility-based health workers.
more
This is the first national Policy to combat AMR in Cambodia. It was developed based on conclusions and recommendations of a country situaytion analysis.
Senegal is on course to meet the global target for under-five overweight, but is off course to meet the targets for all other indicators analysed with adequate data.